Results 91 to 100 of about 1,365 (154)

The Histamine Pathway is a Target to Treat Hepatic Experimental Erythropoietic Protoporphyria. [PDF]

open access: yesCell Mol Gastroenterol Hepatol
Kuo N   +5 more
europepmc   +1 more source

Quality of life in children with erythropoietic protoporphyria: a case-control study. [PDF]

open access: yesJ Dermatol
Kluijver LG   +6 more
europepmc   +1 more source

Light-Related Cutaneous Symptoms of Erythropoietic Protoporphyria and Associations With Light Sensitivity Measurements.

open access: yesJAMA Dermatol, 2023
Raef HS   +10 more
europepmc   +1 more source

German Cohort Observational Study to Investigate the Short- and Long-Term Safety and Clinical Effectiveness of Afamelanotide 16 mg (SCENESSE) in Patients With Erythropoietic Protoporphyria (EPP). [PDF]

open access: yesPhotodermatol Photoimmunol Photomed
Homey B   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy